Sai Life Sciences commences commercial operation of 2nd phase in Bidar
This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio
Subscribe To Our Newsletter & Stay Updated